Completed NA INTERVENTIONAL 2-arm NCT02510820

The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems

Sponsor: CooperVision, Inc.

Conditions Myopia

Interventions Biotrue Synergi comfilcon A stenfilcon A

Updated 8 times since 2017 Last updated: Jan 30, 2017 Started: May 31, 2015 Primary completion: Sep 30, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Myopia and is currently completed. CooperVision, Inc. leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

May 2025 — Present [monthly]

Completed NA
Jan 2025 — May 2025 [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

Phase: PHASE4 → NA
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CooperVision, Inc.

Data source: CooperVision International Limited (CVIL)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manchester, United Kingdom